For the Inventor, By the Inventor

Enter inventor name

Glen Mills, PA, United States of America

Magid A Abou-Gharbia

USPTO Granted Patents = 116 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 2.4

ph-index = 22

Forward Citations = 1,793(Granted Patents)

Forward Citations (Not Self Cited) = 1,674(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Brandywood, DE (US) (1987)
Gulph Mills, PA (US) (1989)
Delaware, PA (US) (1993)
Glen Mills, PA (US) (1989 - 1996)
Glenn Mills, PA (US) (1996)
Wilmington, DE (US) (1984 - 1998)
Princeton Junction, NJ (US) (2002 - 2004)
Exton, PA (US) (2004 - 2024)

Company Filing History:

91 out of 1,567

American Home Products Corporation

Temple University

4. 2 out of 366

Research Corporation Technologies, Inc.

John Wyeth & Bro., Limited

6. 1 out of 299

John Wyeth Brother, Limited

Shifa Biomedical Corporation

Cortendo Ab (Publ)

where one patent can have more than one assignee

Years Active: 1984-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

5-Hydroxytryptamine Receptor 7

Aminothiazole Compounds

Beta Lactams

Glutamate Uptake

Anti-Pcsk9 Compounds

Cytochrome P450 Inhibitors

Serotonin 5-HT1A Activity

Carbamates Of Rapamycin

dibenzo[a,d]cycloheptene Nmda Antagonists

Venlafaxine

Aryl- And Heteroaryl Piperazinyl Carboxamides

Cognition Enhancement

116 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503458 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2025-12-23),

2. 12269809 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2025-04-08),

3. 11897870 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2024-02-13),

4. 11873267 - Functionalized N,N-dialkylamino phenyl ethers and their method of use (2024-01-16),

5. 11787794 - Aminothiazole compounds and methods using same (2023-10-17),

6. 11325883 - Functionalized N,N-dialkylamino phenyl ethers and their method of use (2022-05-10),

7. 11192871 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2021-12-07),

8. 10941126 - Bridged bicycloalkyl-substituted aminothiazoles and their methods of use (2021-03-09),

9. 10759750 - Beta lactams as modulators of glutamate uptake and methods for use thereof (2020-09-01),

10. 10676464 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2020-06-09),

11. 10544117 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2020-01-28),

12. 10287274 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2019-05-14),

13. 10239868 - 5-hydroxytryptamine receptor 7 activity modulators and their method of use (2019-03-26),

14. 10131637 - Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases (2018-11-20),

15. 9975879 - Beta lactams as modulators of glutamate uptake and methods for use thereof (2018-05-22),

Title: The Innovative Journey of Magid A Abou-Gharbia

Introduction: Magid A Abou-Gharbia, a renowned inventor based in Glen Mills, PA (US), has made significant contributions to the field of pharmaceuticals through his groundbreaking innovations.

Latest Patents: Magid A Abou-Gharbia holds several patents in the pharmaceutical industry, focusing on novel drug compounds and formulations that have the potential to revolutionize medical treatments.

Career Highlights: With a distinguished career spanning several decades, Magid A Abou-Gharbia has held key positions in leading research institutions and pharmaceutical companies, where he has led teams in developing cutting-edge medications.

Collaborations: Throughout his career, Magid A Abou-Gharbia has collaborated with top researchers, scientists, and institutions globally, fostering a culture of innovation and excellence in the pharmaceutical field.

Conclusion: Magid A Abou-Gharbia's relentless pursuit of innovation and his passion for advancing healthcare solutions have solidified his reputation as a pioneering inventor in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…